Finance

Lists
MIRA:NASDAQ
Mira Pharmaceuticals Inc
0,73 USD
+0,97%
(+0,0070) 1D
0,72 USD
-1,36% (-0,0099)
After hours
Closed: 2-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MIRA...
Open
0,73 USD
High
0,76 USD
Low
0,71 USD
Mkt. cap
30,80 млн
Avg. vol.
1,15 млн
Volume
158,39 миң
52-wk high
2,45 USD
52-wk low
0,60 USD
EPS
-1,38 USD
Beta
1,48
Shares outstanding
42,02 млн
No. of employees
3
Open
0,73 USD
High
0,76 USD
Low
0,71 USD
Mkt. cap
30,80 млн
Avg. vol.
1,15 млн
Volume
158,39 миң
52-wk high
2,45 USD
52-wk low
0,60 USD
EPS
-1,38 USD
Beta
1,48
Shares outstanding
42,02 млн
No. of employees
3
News stories
From web sources and news partners
Foreign Policy Journal
Foreign Policy Journal
·
34 мүнөт мурун
SoundHound AI (NASDAQ: SOUN) Stock Drops 3.47% As Broader Market Rallies On Strong Session
Business Insider
Business Insider
·
15 саат мурун
The NYSE's Most Famous Floor Trader Says AI Can't Take His Job
The Motley Fool
The Motley Fool
·
3 саат мурун
History Says Coca-Cola Stock Holds Up When the S&P 500 Falls
Yahoo Finance
Yahoo Finance
·
11 саат мурун
Does S&P Stand for SPooky During October?
About Mira Pharmaceuticals Inc
CEO-
Employees3
Founded2020
HeadquartersМайами, Флорида, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websitemirapharmaceuticals.com
Analyst ratings
Based on 1 analyst giving stock ratings to MIRA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for MIRA in the last 3 months
Highest
Current 0,73 USD
3,50 USD (+379,45%)
Average
3,50 USD (+379,45%)
Lowest
3,50 USD (+379,45%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Initiated
3,50 USD
+379,5%
09/17/2026
Michael King
Rodman & Renshaw
Buy
Initiated
8,00 USD
+995,9%
01/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
412,64 миң
496,54 миң
524,78 миң
705,79 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
904,35 миң
5,33 млн
578,70 миң
450,33 миң
Operating expense
1,32 млн
5,82 млн
1,10 млн
1,16 млн
Total operating expenses
1,32 млн
5,82 млн
1,10 млн
1,16 млн
Operating income
-1,32 млн
-5,82 млн
-1,10 млн
-1,16 млн
Other non operating income
-12,44 миң
-396,00
-
-
EBT including unusual items
-1,14 млн
-5,98 млн
-1,15 млн
-1,21 млн
EBT excluding unusual items
-1,31 млн
-5,77 млн
-1,15 млн
-1,21 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,14 млн
-5,98 млн
-1,15 млн
-1,21 млн
Net profit margin
-
-
-
-
Earnings per share
-0,07
-
-
-
Interest and investment income
15,70 миң
53,17 миң
44,91 миң
35,13 миң
Interest expense
-
-
-
-
Net interest expenses
15,70 миң
53,17 миң
44,91 миң
35,13 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору